Abstract
In skeletal pathology diagnosis, most tumors and tumorlike conditions can be diagnosed with routine hematoxylin and eosin (H&E) stain, but sometimes this basic technique can be insufficient. Histochemical methods evaluate the state of the ossification process and intracellular activated enzymes (PAS, mucin stain, Congo red, von Kossa, etc.). Electron microscopy, flow cytometry, and histomorphometry have limited diagnostic uses. Immunohistochemical staining has been a helpful aid, especially in the diagnosis of round-cell tumors, metastatic disease, Langerhans cell histiocytosis, and vascular tumors. Karyotyping, molecular cytogenetic techniques such as FISH, and molecular techniques like blotting, PCR, and others have limited but effective application in the diagnosis of some specific bone tumors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Reference
Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell. 2011;144:27–40.
Suggested Reading
Alwine JC, Kemp DJ, Stark GR. Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proc Natl Acad Sci U S A. 1977;74:5350–4.
Amary F, Berisha F, Ye H, Gupta M, Gutteridge A, Baumhoer D, et al. H3F3A (Histone 3.3) G34W immunohistochemistry: a reliable marker defining benign and malignant giant cell tumor of bone. Am J Surg Pathol. 2017;41:1059–68.
Andersson C, Fagman H, Hansson M, Enlund F. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing. Cancer Genet. 2016;209:154–60.
Arnould L, Denoux Y, MacGrogan G, Penault-Llorca F, Fiche M, Treilleux I, et al. Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer. Br J Cancer. 2003;88:1587–91.
Bartlett JMS, Stirling D. A short history of the polymerase chain reaction. Methods Mol Biol. 2003;226:3–6.
Bayani J, Squire JA. Fluorescence in situ hybridization. Curr Protoc Cell Biol. 2004;23:22.4.1–52.
Bayani J, Squire JA. Multi color FISH techniques. Curr Protoc Cell Biol. 2004;23:22.5.1–25.
Bermingham N, Luettich K. Polymerase chain reaction and its applications. Curr Diagn Pathol. 2003;9:159–64.
Bickmore WA. Karyotype analysis and chromosome banding encyclopedia of life science. London: Nature Publishing Group; 2001.
Bignell GR, Greenman CD, Davies H, Butler AP, Edkins S, Andrews JM, et al. Signatures of mutation and selection in the cancer genome. Nature. 2010;463:893–8.
Boggs BA, Chinault AC. Analysis of DNA replication by fluorescence in situ hybridization. Methods. 1997;13:259–70.
Brown T. Southern blotting. Curr Protoc Immunol. 2001;Suppl 6:10.6.1–12.
Bustin SA, Mueller R. Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis. Clin Sci. 2005;109:365–79.
Cardona-Castro N, Agudelo-Florez P. Immunoenzymatic dot-blot test for the diagnosis of enteric fever caused by Salmonella typhi in an endemic area. Clin Microbiol Infect. 1998;4:64–9.
Davis JL, Horvai AE. Special AT-rich sequence-binding protein 2 (SATB2) expression is sensitive but may not be specific for osteosarcoma as compared with other high-grade primary bone sarcomas. Histopathology. 2016;69:84–90.
Ekong R, Wolf J. Advances in fluorescent in situ hybridization. Curr Opin Biotechnol. 1998;9:19–24.
Fadiel A, Naftolin F. Microarray applications and challenges: a vast array of possibilities. Int Arch Biosci. 2003;2003:1111–21.
Francke U. Digitized and differentially shaded human chromosome ideograms for genomic applications. Cytogenet Cell Genet. 1994;65:206–19.
Geigl JB, Uhrig S, Speicher MR. Multiplex-fluorescence in situ hybridization for chromosome karyotyping. Nat Protoc. 2006;1:1172–84.
Goswami RS, Luthra R, Singh RR, Patel KP, Routbort MJ, Aldape KD, et al. Identification of factors affecting the success of next-generation sequencing testing in solid tumors. Am J Clin Pathol. 2016;145:222–37.
Gruver AM, Peerwani Z, Tubbs RR. Out of the darkness and into the light: bright field in situ hybridisation for delineation of ERBB2 (HER2) status in breast carcinoma. J Clin Pathol. 2010;63:210–9.
Gupte A, Baker EK, Wan SS, Stewart E, Loh A, Shelat AA, et al. Systematic screening identifies dual PI3K and mTOR inhibition as a conserved therapeutic vulnerability in osteosarcoma. Clin Cancer Res. 2015;21:3216–29.
Higuchi R, Dollinger G, Walsh PS, Griffith R. Simultaneous amplification and detection of specific DNA-sequences. Bio/Technology. 1992;10:413–7.
Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 1992;258:818–21.
King RC, Stansfield WD, Mulligan PK. A dictionary of genetics. seventh ed. Oxford: Oxford University Press; 2006.
Kubista M, Andrade JM, Bengtsson M, Forootan A, Jona J, Lind K, et al. The real-time polymerase chain reaction. Mol Asp Med. 2006;27:95–125.
Kumar RM. The widely used diagnostics “DNA Microarray”--a review. Am J Infect Dis. 2009;5:207–18.
Lambros MBK, Natrajan R, Reis-Filho JS. Chromogenic and fluorescent in situ hybridization in breast cancer. Hum Pathol. 2007;38:1105–22.
Lashkari DA, DeRisi JL, McCusker JH, Namath AF, Gentile C, Hwang SY, et al. Yeast microarrays for genome wide parallel genetic and gene expression analysis. Proc Natl Acad Sci U S A. 1997;94:13057–62.
Maskos U, Southern EM. Oligonucleotide hybridizations on glass supports: a novel linker for oligonucleotide synthesis and hybridization properties of oligonucleotides synthesised in situ. Nucleic Acids Res. 1992;20:1679–84.
Mearns G, Richmond SJ, Storey CC. Sensitive immune dot blot test for diagnosis of Chlamydia trachomatis infection. J Clin Microbiol. 1988;26:1810–3.
Moelans CB, de Weger RA, der Wall V, van Diest PJ. Current technologies for HER2 testing in breast cancer. Crit Rev Oncol Hematol. 2011;80:380–92.
Oostlander AE, Meijer GA, Ylstra B. Microarray-based comparative genomic hybridization and its applications in human genetics. Clin Genet. 2004;66:488–95.
Pei J, Jhanwar SC, Testa JR. Chromothripsis in a case of TP53-deficient chronic lymphocytic leukemia. Leuk Res Rep. 2012;1:4–6.
Pinkel D, Albertson DG. Comparative genomic hybridization. Annu Rev. Genomics Hum Genet. 2005;6:331–54.
Rosa FE, Santos RM, Rogatto SR, Domingues MAC. Chromogenic in situ hybridization compared with other approaches to evaluate HER2/neu status in breast carcinomas. Braz J Med Biol Res. 2013;46:207–16.
Saiki R, Scharf S, Faloona F, Mullis K, Horn G, Erlich H, Arnheim N. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985;230:1350–4.
Sambrook J, Russel DW. Molecular cloning: a laboratory manual. third ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 2001.
Šášik R, Woelk CH, Corbeil J. Microarray truths and consequences. J Mol Endocrinol. 2004;33:1–9.
Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 1995;270:467–70.
Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci U S A. 1996;93:10614–9.
Seidel C. Introduction to DNA microarrays, analysis of microarray data: a network-based approach. Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim; 2008.
Streit S, Michalski CW, Erkan M, Kleef J, Friess H. Northern blot analysis for detection of RNA in pancreatic cancer cells and tissues. Nat Protoc. 2009;4:37–43.
Tanner M, Gancberg D, Di Leo A, Larsimont D, Rouas G, Piccart MJ, Isola J. Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER2/neu oncogene amplification in archival breast cancer samples. Am J Pathol. 2000;157:1467–72.
Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:4350–4.
Vera-Cabrera L, Rendon A, Diaz-Rodriguez M, Handzel V, Laszlo A. Dot blot assay for detection of antidiacyltrehalose antibodies in tuberculous patients. Clin Diagn Lab Immunol. 1999;6:686–9.
Vorsanova SG, Yurov YB, Iourov IY. Human interphase chromosomes: a review of available molecular cytogenetic technologies. Mol Cytogenet. 2010;3:1–15.
Weiss MM, Hermsen MA, Meijer GA, Grieken NC, Baak JP, Kuipers EJ, van Diest PJ. Comparative genomic hybridization. Mol Pathol. 1999;52:243–51.
Wong ML, Medrano JF. Real-time PCR for mRNA quantitation. BioTechniques. 2005;39:75–85.
Wyatt AW, Collins CC. In brief: chromothripsis and cancer. J Pathol. 2013;231:1–3.
Zhang N, Liu H, Yue G, Zhang Y, You J, Wang H. Molecular heterogeneity of Ewing sarcoma as detected by ion torrent sequencing. PLoS One. 2016;11:e0153546.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Na, K., Park, YK. (2020). Basic and Ancillary Techniques in Bone Pathology. In: Santini-Araujo, E., Kalil, R.K., Bertoni, F., Park, YK. (eds) Tumors and Tumor-Like Lesions of Bone. Springer, Cham. https://doi.org/10.1007/978-3-030-28315-5_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-28315-5_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-28314-8
Online ISBN: 978-3-030-28315-5
eBook Packages: MedicineMedicine (R0)